Navinci Featured in BioStock
Navinci has been featured in an article by BioStock highlighting the company’s unique technology and future ambitions.
Professor Joakim Lundeberg Joins Navinci’s Board of Directors
Professor Joakim Lundeberg, a world-leading expert in molecular biotechnology and spatial biology, has joined Navinci’s Board of Directors.
Navinci Launches Naveni® Plex Omni Service Providing Expert-Led Access to Spatial Interactomics
Navinci is proud to announce the launch of the Naveni® Plex Omni Service, giving researchers access to cutting edge multiplex isPLA technology.
Vector Laboratories Launches Glysite™ Explorer in situ PLA Glycan Detection Kit to Advance Functional Proteomics Research
Vector Laboratories Launches Glysite™ Explorer in situ PLA Glycan Detection Kit to Advance Functional Proteomics Research
Navinci Secures €5.3 Million in Funding from Existing Owners and a Strategic Investment from Jonathan Milner at Meltwind
The funds will be used to accelerate product development, strengthen operations, and position the company for its next phase of growth.
Spatial Interactomics Grant 2025
Navinci is proud to announce the launch of the 2025 Spatial Interactomics Grant Program, inviting researchers from across the globe to push the boundaries of proteomics and spatial biology.
Navinci Appoints Magnus Hurst as New Chief Financial Officer
Navinci is pleased to announce the appointment of Magnus Hurst as its Chief Financial Officer (CFO), marking the next phase of growth for the company.
Jenny Sundqvist appointed CEO of Navinci
Navinci’s Board of Directors is pleased to announce the appointment of Jenny Sundqvist as the new Chief Executive Officer, effective December 1, 2024.
Precision for Medicine and Navinci Announce Strategic Partnership
A partnership announced between Precision for Medicine and Navinci to offer isPLA as part of Precision for Medicine’s CRO services.
Navinci announces stepping down of CEO, Robert Gunnarsson
Navinci announces CEO Robert Gunnarsson’s resignation, with Agata Zieba-Wicher as interim leader while the board searches for a permanent successor.
Partnership announced between Canopy Biosciences and Navinci
A partnership announced between Canopy Biosciences and Navinci to offer isPLA as part of Canopy’s CRO services.
Leica Biosystems and Navinci Partner to Accelerate Cancer Research
Leica Biosystems, a global leader in anatomic pathology, and Navinci, announce a strategic collaboration to drive innovation in cancer patient care.